Who we are
Who we are
We Are Passionate About COA Research
The TPT Story
The TPT Story
This is our story…
Founded in 2023 by Daniel Serrano, The Psychometrics Team aims to emphasize quality and efficiency.
The idea behind TPT was to disrupt the current consulting paradigm. Private equity has consolidated several speciality and boutique COA practices and as such this drives up costs and drives down quality.
Here at TPT, we focus on the research and love what we do!
Photo (© Serrano, D. Lake Louise, Canada):
Photo (© Serrano, D. Lake Louise, Canada):
Photo (© Serrano, D. Lake Louise, Canada):
Our team
Our team
Our team
Meet the team
We're leading experts in the field of COA research . Learn more about us.
Founder & Scientific/Strategy Lead
Daniel Serrano, PhD
20+ years of experience in COA research. Built and led two psychometrics teams from 2014 to 2017 and then from 2017 to 2023. Expertise in: • COA regulatory strategy (FDA, EMA, NMPA, PMDA) • COA measure/endpoint development/validation • Psychometrics • Advanced biostatistics applications for post-approval differentiation • Led COA development/validation of measures in 21+ disease areas including neurology, rare disease, oncology, respiratory disease, psychiatry, vision, dermatology, rheumatology, inflammatory bowel disease
20+ years of experience in COA research. Built and led two psychometrics teams from 2014 to 2017 and then from 2017 to 2023. Expertise in: • COA regulatory strategy (FDA, EMA, NMPA, PMDA) • COA measure/endpoint development/validation • Psychometrics • Advanced biostatistics applications for post-approval differentiation • Led COA development/validation of measures in 21+ disease areas including neurology, rare disease, oncology, respiratory disease, psychiatry, vision, dermatology, rheumatology, inflammatory bowel disease
20+ years of experience in COA research. Built and led two psychometrics teams from 2014 to 2017 and then from 2017 to 2023. Expertise in: • COA regulatory strategy (FDA, EMA, NMPA, PMDA) • COA measure/endpoint development/validation • Psychometrics • Advanced biostatistics applications for post-approval differentiation • Led COA development/validation of measures in 21+ disease areas including neurology, rare disease, oncology, respiratory disease, psychiatry, vision, dermatology, rheumatology, inflammatory bowel disease
Director, Patient-Centered Outcomes
Lauren Podger, MSc
8 years of experience in COA research. Expertise in: • COA regulatory strategy (FDA, EMA, PMDA) • COA measure/endpoint development/validation • Psychometrics • Clinical study design and COA data analysis • Led or supported COA development/validation of measures/endpoints in rare disease, oncology, respiratory disease, autoimmune disease, neurology, inflammatory bowel disease, vision, dermatology
8 years of experience in COA research. Expertise in: • COA regulatory strategy (FDA, EMA, PMDA) • COA measure/endpoint development/validation • Psychometrics • Clinical study design and COA data analysis • Led or supported COA development/validation of measures/endpoints in rare disease, oncology, respiratory disease, autoimmune disease, neurology, inflammatory bowel disease, vision, dermatology
8 years of experience in COA research. Expertise in: • COA regulatory strategy (FDA, EMA, PMDA) • COA measure/endpoint development/validation • Psychometrics • Clinical study design and COA data analysis • Led or supported COA development/validation of measures/endpoints in rare disease, oncology, respiratory disease, autoimmune disease, neurology, inflammatory bowel disease, vision, dermatology
How we work
How we work
How we work
We do good work, on time
Our team is focused on working with clients to identify and deliver an optimal COA strategy that meets their specific research need and key milestones.
Collaboration
We view our clients as research partners and seek to be the same for them. Our aim is to foster collaboration with all project stakeholders. We understand that our clients often work as part of a wider team within their organization, and as such this is reflected within our approach throughout the project lifecycle.
Collaboration
We view our clients as research partners and seek to be the same for them. Our aim is to foster collaboration with all project stakeholders. We understand that our clients often work as part of a wider team within their organization, and as such this is reflected within our approach throughout the project lifecycle.
Collaboration
We view our clients as research partners and seek to be the same for them. Our aim is to foster collaboration with all project stakeholders. We understand that our clients often work as part of a wider team within their organization, and as such this is reflected within our approach throughout the project lifecycle.
Specialists
We pride ourselves on having specialist training, decades of hands-on experience specific to our service offerings.
Specialists
We pride ourselves on having specialist training, decades of hands-on experience specific to our service offerings.
Specialists
We pride ourselves on having specialist training, decades of hands-on experience specific to our service offerings.
Thoughtful
One size does not fit all. Not every psychometric validation study is the same. We understand that each research project will have unique challenges or considerations (e.g., study design, sample size, natural history of disease, missing data) and have the expertise to rise and meet these challenges to yield the needed solutions. We believe in practice first principles in all that we do.
Thoughtful
One size does not fit all. Not every psychometric validation study is the same. We understand that each research project will have unique challenges or considerations (e.g., study design, sample size, natural history of disease, missing data) and have the expertise to rise and meet these challenges to yield the needed solutions. We believe in practice first principles in all that we do.
Thoughtful
One size does not fit all. Not every psychometric validation study is the same. We understand that each research project will have unique challenges or considerations (e.g., study design, sample size, natural history of disease, missing data) and have the expertise to rise and meet these challenges to yield the needed solutions. We believe in practice first principles in all that we do.
Transparency
A cornerstone of trust. We maintain open, honest dialogues with our clients.
Transparency
A cornerstone of trust. We maintain open, honest dialogues with our clients.
Transparency
A cornerstone of trust. We maintain open, honest dialogues with our clients.
Committed
Ultimately, we love what do and don’t stop until we get it right.
Committed
Ultimately, we love what do and don’t stop until we get it right.
Committed
Ultimately, we love what do and don’t stop until we get it right.
The TPT playlist
The TPT playlist
The TPT playlist
What we're listening to in the office…
On repeat.
Have a chat with us
Got any questions? Contact us and we'll be happy to help.